Does the 2-methylthiomethyl substituent really confer high anti-HIV-1 activity to S-DABOs?

Medicinal Chemistry Research

Volumn 10, Issue 1, 2000, Pages 30-39

  Sbardella, Gianluca ^a   Mai, Antonello ^a   Artico, Marino ^a   Massa, Silvio ^b   Marceddu, Tiziana ^c   Vargiu, Laura ^c   Marongiu, Maria Elena ^c   La Colla, Paolo ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIHYDRO ALKYLTHIO BENZYL OXOPYRIMIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0033943608     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1. Mai, A.; Artico, M.; Sbardella, G.; Massa, S.; Loi, A.G.; Tramontano, E.; Scano, P.; La Colla, P. J. Med. Chem. 1995, 38, 3258-3263.
2. 2. Ettorre, A.; Mai, A.; Artico, M.; Massa, S.; La Colla, P. Acta Crystallographica 1996, C52, 2115-2117.
3. 3. Marongiu, M.E.; Pani, A.; Artico, M.; Massa, S.; Mai, A.; La Colla, P. VIII International Conference on AIDS. Amsterdam 1992, 19-24 July, Po A 2315.
4. 4. Mai, A.; Massa, S.; Artico, M.; La Colla, P.; Marongiu, M.E.; Pani, A. Januachem 92. Genova 1992, 25-30 October FP80.
5. 5. Botta, M.; Artico, M.; Massa, S.; Gambacorta, A.; Marongiu, M.E.; Pani, A.; La Colla, P. Eur. J. Med. Chem. 1992, 27, 251-257.
6. 6. Artico, M.; Massa, S.; Mai, A.; Marongiu, M.E.; Piras, G.; Tramontano, E.; La Colla, P. Antivir. Chem. Chemother. 1993, 4, 361-368.
7. 7. Tramontano, E.; Marongiu, M.E.; De Montis, A.; Loi, A.G.; Artico, M.; Massa, S.; Mai, A.; La Colla, P. Microbiologica 1994, 17, 269-279.
8. 8. Massa, S.; Mai, A.; Artico, M.; Sbardella, G.; Tramontano, E.; Loi, A.G.; Scano, P.; La Colla, P. Antivir. Chem. Chemother. 1995, 6, 1-8.
9. 9. Mai, A.; Artico, M.; Sbardella, G.; Quartarone, S.; Massa, S.; Loi, A.G.; De Montis, A.; Scintu, F.; Putzolu, M.; La Colla, P. J. Med. Chem. 1997, 40, 1447-1454.
10. 10. Mai, A.; Artico, M.; Sbardella, G.; Massa, S.; Novellino, E.; Greco, G.; Loi, A.G.; Tramontano, E.; Marongiu, M.E.; La Colla, P. J. Med. Chem. 1999, 42, 619-627.
11. 11. Sbardella, G.; Mai, A.; Artico, M.; Massa, S.; Marceddu, T.; Vargiu, L.; Marongiu, M.E.; La Colla, P. Antivir. Chem. Chemother. submitted.
12. 12. Danel, K.; Larsen, E.; Pedersen, E.B. Synthesis 1995, 934-936.
13. 13. Danel, K.; Nielsen, C.; Pedersen, E.B. Acta Chem. Scand. 1997, 51, 426-430.
14. 14. Danel, K.; Pedersen, E.B.; Nielsen, C. J. Med. Chem. 1998, 41, 191-198.
15. 15. Nizi, E.; Botta, M.; Corelli, F.; Manetti, F.; Messina, F.; Maga, G. Tetrahedron Letters 1998, 3307-3310.
16. 16. Vig, R.; Mao, C.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Sudbeck, E.A.; Uckun, F.M. Bioorg. Med. Chem. Letters 1998, 8, 1461-1466.
17. 17. Sudbeck, E.A.; Mao, C.; Vig, R.; Venkatachalam, T.K.; Tuel-Ahlgren, L.; Uckun, F.M. Antimicrob. Agents & Chemother. 1998, 42, 3225-3233.
18. 18. Baba, M.; Shigeta, S.; Yuasa, S.; Takashima, H.; Sekiya, K.; Ubasawa, M.; Tanaka, H.; Miyasaka, T.; Walker, R.T.; De Clercq, E. Preclinical Evaluation of MKC-442, a Highly Potent and Specific Inhibitor of Human Immunodeficiency Virus Type 1 in Vitro. Antimicrob. Agents Chemother. 1994, 38, 688-692.
19. 19 Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Nitta, I.; Baba, M.; Shigeta, S.; Walker, R.T.; De Clercq, E.; Miyasaka, T. J. Med. Chem. 1992, 35, 337-345.
20. 20. Tanaka, H.; Takashima, H.; Ubasawa, M.; Sekiya, K.; Inouye, N.; Baba, M.; Shigeta, S.; Walker, R.T.; De Clercq, E.; Miyasaka, T. J. Med. Chem. 1995, 38, 2860-2865.
21. 21. Pauwels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Schols, D.; Herdewijn, P.; Desmyster, J.; De Clercq, E. J. Virol. Methods 1988, 20, 309-321.
22. 22. Rooke, R.; Tremblay, M.; Wainberg, M.A. Virology 1990, 176, 205-215.